Cargando…

The role of GLI1 for 5-Fu resistance in colorectal cancer

Colorectal cancer is a leading cause of cancer-related mortality worldwide, with Fluorouracil (5-FU)-based chemotherapy as the major treatment for advanced disease. Many patients with advanced colorectal cancer eventually succumb to the disease despite some patients responded initially to chemothera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Lining, Song, Ruolan, Gu, Dongsheng, Zhang, Xiaoli, Yu, Beiqin, Liu, Bingya, Xie, Jingwu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390459/ https://www.ncbi.nlm.nih.gov/pubmed/28413604 http://dx.doi.org/10.1186/s13578-017-0145-7

Ejemplares similares

GLI1-mediated regulation of side population is responsible for drug resistance in gastric cancer
por: Yu, Beiqin, et al.
Publicado: (2017)

Regulation of pancreatic cancer metastasis through the Gli2-YAP1 axis via regulation of anoikis
por: Yu, Beiqin, et al.
Publicado: (2022)

The role of GLI-SOX2 signaling axis for gemcitabine resistance in pancreatic cancer
por: Jia, Yanfei, et al.
Publicado: (2018)

Aspirin suppresses chemoresistance and enhances antitumor activity of 5-Fu in 5-Fu-resistant colorectal cancer by abolishing 5-Fu-induced NF-κB activation
por: Fu, Jinbo, et al.
Publicado: (2019)

Inhibition of CDK1 Reverses the Resistance of 5-Fu in Colorectal Cancer
por: Zhu, Yiping, et al.
Publicado: (2020)

Combinational inhibition of EGFR and YAP reverses 5-Fu resistance in colorectal cancer
por: Huang, Changhao, et al.
Publicado: (2020)

Wnt pathway is involved in 5-FU drug resistance of colorectal cancer cells
por: He, Lingfeng, et al.
Publicado: (2018)

Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell lines
por: Suetsugu, Tomonari, et al.
Publicado: (2021)

TIMP-2 regulates 5-Fu resistance via the ERK/MAPK signaling pathway in colorectal cancer
por: Zhang, Guolin, et al.
Publicado: (2022)

Targeting REV7 effectively reverses 5-FU and oxaliplatin resistance in colorectal cancer
por: Sun, Xianjun, et al.
Publicado: (2020)

Overexpression of sortilin is associated with 5‐FU resistance and poor prognosis in colorectal cancer
por: Blondy, Sabrina, et al.
Publicado: (2020)

Managing 5FU Cardiotoxicity in Colorectal Cancer Treatment
por: Anaka, Matthew, et al.
Publicado: (2022)

DCBLD2 Affects the Development of Colorectal Cancer via EMT and Angiogenesis and Modulates 5-FU Drug Resistance
por: Xie, Pan, et al.
Publicado: (2021)

METTL3 antagonizes 5-FU chemotherapy and confers drug resistance in colorectal carcinoma
por: Li, Min, et al.
Publicado: (2022)

METTL3 antagonizes 5-FU chemotherapy and confers drug resistance in colorectal carcinoma
por: Li, Min, et al.
Publicado: (2023)

Deciphering the role of hedgehog signaling in pancreatic cancer
por: Gu, Dongsheng, et al.
Publicado: (2016)

Exosomal transfer of p-STAT3 promotes acquired 5-FU resistance in colorectal cancer cells
por: Zhang, Qian, et al.
Publicado: (2019)

5-FU Metabolism in Cancer and Orally-Administrable 5-FU Drugs
por: Miura, Koh, et al.
Publicado: (2010)

Determining the optimal 5-FU therapeutic dosage in the treatment of colorectal cancer patients
por: Fang, Ling, et al.
Publicado: (2016)

Halofuginone inhibits tumorigenic progression of 5-FU-resistant human colorectal cancer HCT-15/FU cells by targeting miR-132-3p in vitro
por: Wang, Chen, et al.
Publicado: (2020)

FOXM1 modulates 5-FU resistance in colorectal cancer through regulating TYMS expression
por: Varghese, Vidhya, et al.
Publicado: (2019)

Predicting Agents That Can Overcome 5-FU Resistance in Colorectal Cancers via Pharmacogenomic Analysis
por: Huang, Tsui-Chin, et al.
Publicado: (2021)

Review of 5-FU resistance mechanisms in colorectal cancer: clinical significance of attenuated on-target effects
por: Gmeiner, William H., et al.
Publicado: (2023)

Knockout of SIRT4 decreases chemosensitivity to 5-FU in colorectal cancer cells
por: Zhu, Yuanyuan, et al.
Publicado: (2018)

Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery
por: De Angelis, Paula M, et al.
Publicado: (2006)

Factors predicting efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU) ± folinic acid in a compassionate-use cohort of 481 5-FU-resistant advanced colorectal cancer patients
por: Bensmaïne, M A, et al.
Publicado: (2001)

Non-Canonical Hh Signaling in Cancer—Current Understanding and Future Directions
por: Gu, Dongsheng, et al.
Publicado: (2015)

Hypermethylated FAM5C and MYLK in Serum as Diagnosis and Pre-Warning Markers for Gastric Cancer
por: Chen, Lu, et al.
Publicado: (2012)

A critical role of AREG for bleomycin-induced skin fibrosis
por: Zhang, Mary Yinghua, et al.
Publicado: (2021)

LncRNA NEAT1 remodels chromatin to promote the 5-Fu resistance by maintaining colorectal cancer stemness
por: Zhu, Yihao, et al.
Publicado: (2020)

Sonidegib: mechanism of action, pharmacology, and clinical utility for advanced basal cell carcinomas
por: Jain, Sachin, et al.
Publicado: (2017)

HES1 Promotes Colorectal Cancer Cell Resistance To 5-Fu by Inducing Of EMT and ABC Transporter Proteins
por: Sun, Lei, et al.
Publicado: (2017)

Loss of ABCB4 attenuates the caspase-dependent apoptosis regulating resistance to 5-Fu in colorectal cancer
por: Hu, Hanqing, et al.
Publicado: (2018)

RPL22L1 induction in colorectal cancer is associated with poor prognosis and 5-FU resistance
por: Rao, Shuyun, et al.
Publicado: (2019)

Combined Therapeutic Effects of (131)I-Labeled and 5Fu-Loaded Multifunctional Nanoparticles in Colorectal Cancer
por: Wu, Pingping, et al.
Publicado: (2020)

CTCF promotes colorectal cancer cell proliferation and chemotherapy resistance to 5-FU via the P53-Hedgehog axis
por: Lai, Qiuhua, et al.
Publicado: (2020)

A mechanism for vertebrate Hedgehog signaling: recruitment to cilia and dissociation of SuFu–Gli protein complexes
por: Tukachinsky, Hanna, et al.
Publicado: (2010)

Nek2A/SuFu feedback loop regulates Gli-mediated Hedgehog signaling pathway
por: Zhou, Fen, et al.
Publicado: (2016)

STAT3 regulates 5‐Fu resistance in human colorectal cancer cells by promoting Mcl‐1–dependent cytoprotective autophagy
por: Yue, Yuanyi, et al.
Publicado: (2023)

Synthesis and Chemopreventive Potential of 5-FU/Genistein Hybrids on Colorectal Cancer Cells
por: Moreno-Quintero, Gustavo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9749q6q64tjtq5vv6b0f5i1isa